| Document |
Document Title |
|
JPH0420435B2 |
Novel alpha -aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benze
neacetontr iles which are effective in destruting and/or preventing the growth of Protozoa; pharmaceutical compositions comprising such compounds as active ingredie...
|
|
JPH0419229B2 |
New cephalosporins are of formula (I) In the formula R and R1 are both H or both hydrolysable or hydrogenolysable gps. or R1 can also be opt. substd. 1-4C alkyl, A is H or an equiv. of an alkali(ne earth) metal or an amine. (I) have anti...
|
|
JPH0419221B2 |
Compounds of the formula I wherein R3 and the NR1R2 group are in a cis-position to each other and wherein Y is OH, R4COO, (R5)2NCOO or R6O either in position 5 or position 7, whereby R4 is an alkyl group having 1-5 carbon atoms or a poss...
|
|
JPH0417947B2 |
A process is disclosed for producing substituted asymmetric ureas, starting from dialkylcarbonates, aromatic amines and aliphatic amines, by a two-step procedure and in the presence of a catalyst selected from among the Lewis' acids and ...
|
|
JPH0415779B2 |
Substituted phenoxyphenylhydroxyamines and pyridyloxyphenylhydroxyamines, and the use thereof for the control of weeds.
|
|
JPH0414643B2 |
The present invention relates to the use of compounds of the formula or pharmacologically acceptable salts thereof, for the preparation of medicaments having immunosuppressive activity.
|
|
JPH0414086B2 |
A process for resolving a racemic modification of beta -adrenergic aryl- or hetaryl-oxypropanolamines such as (+/-)-2-[2-hydroxy-3-[[2-(1_H-indol-3-yl)-1,1-dimethylethyl]
amino]prop oxy]benzonitrile into its individual enantiomers is des...
|
|
JPH049766B2 |
|
|
JPH048427B2 |
(A) Carbacycline derivs. of formulae (X) and (X1) are new. n is 1 or 2. L1 is alpha-R3, beta-R4; beta-R3 or a mixt. of both; R3 and R4 being each H, methyl or fluoro, M1 is alpha-hydroxy, beta-R5 or alpha-R5, beta-hydroxy; R5 being H or ...
|
|
JPH04500815A |
The invention relates to new 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, a process for preparing them and their use as drugs.
|
|
JPH046181B2 |
|
|
JPH044311B2 |
A compound of the formula where R is selected from the group consisting of CH3-CO-(CH2)2-O-, +TR The compounds are useful in treating depression.
|
|
JPH043382B2 |
|
|
JPH043381B2 |
|
|
JPH043380B2 |
|
|
JPH041737B2 |
|
|
JPH04982B2 |
Novel prodrug forms of known non-steroidai anti-inflammatory agents and a process for preparing them are disclosed, said prodrugs having the structural formula wherein R-@- is the acyl residue of a non-steroidal anti-inflammatory agent c...
|
|
JPH0380147B2 |
|
|
JPH0380182B2 |
|
|
JPH03291259A |
PURPOSE: To readily obtain the title compound containing a new compound useful as an intermediate for production of carbapenem based antibiotic used in a medicine in good yield by reacting a specific enolate compound used as a nucleophil...
|
|
JPH0379339B2 |
|
|
JPH0379340B2 |
1,1,1-azidodinitro compounds such as 1,1,1-azidodinitroethane are prepared by reacting the corresponding 1,1,1-trinitromethyl compound with lithium azide in the presence of a dipolar aprotic solvent. 1,1,1-azidodinitro compounds are also...
|
|
JPH0356127Y2 |
|
|
JPH0377178B2 |
|
|
JPH0374817B2 |
A heat-developable color light-sensitive material comprising a support having thereon at least: (1) a light-sensitive silver-halide, (2) a coupler capable of coupling with an oxidation product of a developing agent, (3) a hydrophilic bin...
|
|
JPH0374643B2 |
|
|
JPH0374654B2 |
|
|
JPH0374218B2 |
|
|
JPH03258756A |
NEW MATERIAL:An alkoxyamine derivative expressed by formula I (R1 is 3-5C alkyl; R2 is lower alkyl; n is 2, 3 or 4; either one of A and B is O and the other is -NH-). EXAMPLE: N-[4-(2-Ethylbutyl)phenoxy]propyl-O-ethylhydroxyamine. USE: U...
|
|
JPH0372056B2 |
|
|
JPH0369338B2 |
|
|
JPH0365339B2 |
|
|
JPH0362644B2 |
Hydroxylammonium salts are prepared by an improved process, wherein nitric oxide is reduced catalytically with hydrogen in a dilute aqueous solution of a mineral acid in the presence of a suspended supported platinum catalyst and at elev...
|
|
JPH0361661B2 |
This invention discloses a number of novel odorant oximes having from 11 to 14 carbon atoms, processes for making same, and odorant compositions containing same.
|
|
JPH0361664B2 |
1-[2-(2,4-Dichlorophenyl)-pentyl]-1H-1,2,4-triazole can be produced, in a novel, simple, economical and isomer-free form, by reacting 2-(2,4-dichlorophenyl)-valeronitrile, in the presence of hydrogen, an acid and a hydrogenation catalyst...
|
|
JPH0359897B2 |
|
|
JPH0359899B2 |
|
|
JPH0359075B2 |
|
|
JPH0357132B2 |
The present invention relates to a process for the preparation of polyisocyanates which have a biuret structure of reacting excess quantities of aliphatic diisocyanates with biuretizing agents at elevated temperature, characterized in th...
|
|
JPH0357107B2 |
|
|
JPH0355458B2 |
The present invention relates to novel compositions of matter and novel processes for preparing these compositions of matter. Moreover, there are provided novel methods by which certain of these novel compositions of matter are employed ...
|
|
JPH0354933B2 |
|
|
JPH0354654B2 |
|
|
JPH0353295B2 |
|
|
JPH0353298B2 |
Organo N-hydroxyimidates are prepared by reacting an organonitrile with an organic alcohol and with a hydrogen halide, in the presence of an organic solvent (which may include an excess of the organonitrile reactant), under anhydrous con...
|
|
JPH0350750B2 |
|
|
JPH03173855A |
NEW MATERIAL: A compound of formula I [A means hydroxymethyl, chloromethyl, carboxy, etc.; D means CH, N; n is 0, 1; R means H, alkyl, phenyl, etc.; R1 means H, alkyl, haloalkyl; R2 means H, alkyl; T means H, F; X means H, halogen; Y mea...
|
|
JPH0348180B2 |
|
|
JPH0347256B2 |
Novel alkane derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, or phenyl; R2 is hydrogen, C1-C6 alkyl, or C2-C6 alkenyl; R3 is hydrogen, C1-C10 alkyl, ph...
|
|
JPH0346474B2 |
NEW MATERIAL:A compound of formula I [X is halogen: Y and Z incorporate to form a group, =NR<5> (R<5> is protected hydroxyl)], its salt or ester. EXAMPLE:Ethyl alpha-ethoxyimino-2-aminothiazol-4-ylacetate hydrobromide. USE:A synthetic in...
|
